What is Murepavadin used for?

Murepavadin is being studied as a potential treatment for pneumonia.

How does Murepavadin work?

Murepavadin works by inhibiting the LpD protein, which is necessary for the assembly of lipopolysaccharides.

Is Murepavadin approved for use?

No, Murepavadin is currently in Phase 3 clinical trials and is not yet an approved medication.

What type of drug is Murepavadin?

Murepavadin is a protein-type molecule.

Can Murepavadin treat kidney disease?

While it has been studied in relation to kidney disease in early phases, its primary focus in advanced trials is pneumonia.

Is Murepavadin an oral medication?

The provided data does not specify if Murepavadin is taken by mouth, though it is listed as neither oral, parenteral, nor topical.

murepavadin | CAS 944252-63-5 | RIDRXGOBXZLKHZ

Loading compound...

LPS-assembly protein inhibitor

Murepavadin is a protein-based compound currently in clinical development (Phase 3). It works by inhibiting the LpD protein, which is involved in the assembly of lipopolysaccharides (LPS). It is being studied for its potential to treat pneumonia.

How it worksMurepavadin works by blocking the LpD protein, which helps prevent the assembly of certain bacterial components.

Used for

Pneumonia

Conditions

Pneumonia

Class

LPS-assembly protein inhibitorRespiratory

How to take

Murepavadin is currently an investigational drug in Phase 3 clinical trials and is not yet approved for general use.

Talk to your doctor

Questions to ask

·What stage of clinical trials is Murepavadin currently in?
·How does Murepavadin differ from current pneumonia treatments?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)